Morning Overview on MSN

Nanoparticle therapy targets lung tumors and cancer-related muscle loss

A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...

Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS ...

Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...
Science Daily

Your DNA has a secret “second code” that decides which genes get silenced

Not all parts of our genetic code are equal, even when they appear to say the same thing. Scientists have discovered that ...

S&P 500: This Is Still A Very Weak Market From A Bottom-Up View

But with the story told through more of a bottom-up analysis, of the total membership of the S&P 500 index. That allows me to ...
Journal of Nuclear Medicine Technology

Prostate Cancer, Part 1: Contemporary Radioligands

Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...

约 500 项临床及超万篇研究，EVs/外泌体治疗 6 大疾病探索

据资料显示，截至目前， 已有约 500 项临床试验登记，评估 EVs 相关策略的临床潜力，彰显其在生物医学领域的广阔前景。与此同时，有关 EVs/外泌体的发表文献数量快速增长，根据 PubMed 数据库统计，相关发表文 献数量 2024 年已达到 ...

谁能为辉瑞的收入骤跌救急？

“宇宙大厂”回归现实，急需用新的增长来填补空缺。手握丰厚现金流，今年辉瑞430亿美元收购了Seagen公司，重组肿瘤学部门成为独立业务单元，新任执行副总裁兼首席肿瘤学研发官直接向CEO艾伯乐汇报，但将这一切投入变现都还需要时间。